Letter to the editorIs a guideline based treatment cost-effective for a middle income country? Results from a study with Mexican adolescents
Section snippets
Funding
The Child Psychiatric Hospital covered the costs of the study.
Contributors
R.E.U. designed the study and wrote the protocol. T.S. and L.A. collected the information from the patients' charts, R.E.U. and L.A. performed statistical analyses and wrote the first draft. All authors contributed to editing the manuscript.
Acknowledgement
Authors would like to thank Dr. Francisco de la Rosa for his data review contribution.
References (10)
- et al.
Validity and reliability of the spanish version of the personal and social performance scale in adolescents with schizophrenia
Schizophr. Res.
(2015) - et al.
Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial)
J. Clin. Psychiatry
(2012) - et al.
Economic evaluation of early intervention services
Br. J. Psychiatry Suppl.
(2007) - et al.
Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning
Acta Psychiatr. Scand.
(2000) - et al.
Early intervention for first-episode psychosis: broadening the scope of economic estimates
Early Interv. Psychiatry
(2016)
There are more references available in the full text version of this article.
Cited by (1)
Effectiveness of a treatment guideline for schizophrenia in adolescents: Lessons from a middle-income country
2018, Australian and New Zealand Journal of Psychiatry
© 2017 Elsevier B.V. All rights reserved.